Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-01 Sale | 2023-09-05 5:34 pm | Alaunos Therapeutics Inc. | TCRT | Boyle Kevin S. Sr. Chief Executive Officer | 68,014 | $0.1403 | $9,542 | 798,236 (Direct) | View |
| 2021-11-16 Purchase | 2021-11-17 4:53 pm | ZIOPHARM ONCOLOGY INC | ZIOP | Boyle Kevin S. Sr. Chief Executive Officer | 10,000 | $1.4 | $14,000 | 885,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-15 Option Award | 2023-03-17 8:30 pm | N/A 2033-03-14 | Alaunos Therapeutics Inc. | TCRT | Boyle Kevin S. Sr. Chief Executive Officer | 1,800,000 | $0 | 1,800,000 (Direct) | View |
| 2022-08-30 Tax Withholding | 2022-09-01 4:30 pm | N/A N/A | Alaunos Therapeutics Inc. | TCRT | Boyle Kevin S. Sr. Chief Executive Officer | 18,750 | $2.41 | 866,250 (Direct) | View |
| 2022-03-30 Option Award | 2022-04-01 4:30 pm | N/A 2032-03-29 | Alaunos Therapeutics Inc. | TCRT | Boyle Kevin S. Sr. Chief Executive Officer | 2,000,000 | $0 | 2,000,000 (Direct) | View |
| 2021-08-30 Option Award | 2021-08-31 4:42 pm | N/A 2031-08-29 | ZIOPHARM ONCOLOGY INC | ZIOP | Boyle Kevin S. Sr. Chief Executive Officer | 3,500,000 | $0 | 3,500,000 (Direct) | View |